The pharmaceutical industry worldwide faces increasing difficulties in inventing new products - the industry's lifeblood. As medical needs become more demanding, standards become even higher, and successful research consequently rarer. More critical regulatory authorities also ensure that the development of new compounds into registered pharmaceutical products has become more complex and costly. Whether for strategic reasons in extending a company's product range or maximizing worldwide profits from inventions, or for tactical reasons of increasing market share and reducing R&D or marketing costs, licensing is increasingly seen as an integral part of company planning. The business trend is clear all over the world, led by the largest multinationals. Companies that are more proficient at licensing will strengthen. Those less proficient will tend to decline as they fail to fully exploit their own and others' patents, development organizations and marketing power. In this book, the author draws on his experience at ICI and as an independent consultant to describe the industry's current and future needs in product licensing.
Parallels are drawn between pharmaceutical and agrochemical practice, and a chapter is devoted to licensing and technology transfer in universities. The author points to market trends and gives detailed guidance to technical and marketing professionals who wish to develop or perfect their skills in product licensing. With contributions from acknowledged licensing experts in USA, Japan and Europe, this book offers insights into a subject of key importance for the pharmaceutical and related industries.
- ISBN10 187454509X
- ISBN13 9781874545095
- Publish Date 31 December 1995
- Publish Status Out of Print
- Out of Print 29 August 2012
- Publish Country GB
- Imprint Manson Publishing Ltd
- Format Hardcover
- Pages 320
- Language English